How to convert antihypertensive therapy from amlodipine (calcium channel blocker) 5mg once daily to doxazosin (alpha-1 adrenergic blocker) in a patient with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Amlodipine 5mg to Doxazosin

Stop amlodipine abruptly and start doxazosin 1mg once daily in the morning or evening, then titrate upward every 1-2 weeks based on blood pressure response, monitoring closely for at least 6 hours after each dose adjustment. 1

Direct Conversion Protocol

  • There is no direct dose equivalency between amlodipine and doxazosin—these agents work through completely different mechanisms (calcium channel blockade vs. alpha-1 adrenergic blockade), so you must start doxazosin at its initial recommended dose regardless of the amlodipine dose. 1, 2

  • Discontinue amlodipine 5mg immediately without tapering, as calcium channel blockers do not require gradual withdrawal. 3

  • Start doxazosin at 1mg once daily (either morning or evening) on the same day you stop amlodipine, as this is the FDA-mandated initial dose for hypertension to minimize first-dose hypotensive effects. 1

Titration Schedule

  • Monitor blood pressure for at least 6 hours after the first dose and after each dose increase, as doxazosin can cause significant orthostatic hypotension, particularly with initial dosing. 1

  • Titrate doxazosin by doubling the dose every 1-2 weeks based on blood pressure response: 1mg → 2mg → 4mg → 8mg → 16mg once daily, with a maximum dose of 16mg daily for hypertension. 1

  • Most patients achieve adequate blood pressure control at 2-8mg daily, with mean effective doses around 2.4-13mg in clinical trials. 4, 5

Expected Blood Pressure Response

  • Doxazosin provides 24-hour blood pressure control with once-daily dosing, with mean reductions of approximately 23/13 mmHg in supine position and 24/12 mmHg in standing position at therapeutic doses. 4, 3

  • Full antihypertensive effect develops gradually over 1-2 weeks at each dose level, so allow adequate time before further titration. 2

  • Doxazosin is equally effective in elderly and younger patients, and shows similar efficacy in Black and Caucasian populations. 2

Critical Monitoring Parameters

  • Check both sitting and standing blood pressures at each visit, as doxazosin can cause orthostatic hypotension, particularly in the first few weeks of therapy. 1, 4

  • Reassess blood pressure within 2-4 weeks after starting doxazosin and after each dose adjustment to determine if further titration is needed. 6

  • If therapy is interrupted for several days, restart at the initial 1mg dose and retitrate upward, as the protective adaptation to first-dose effects is lost. 1

Important Clinical Considerations

  • Doxazosin is generally well-tolerated, with side effects typically mild to moderate in severity and often resolving with continued therapy. 2, 4

  • Common adverse effects include dizziness, fatigue, and headache, which are usually transient and decrease with continued use. 2, 5

  • Doxazosin favorably affects lipid profiles, increasing the HDL/total cholesterol ratio compared to placebo, which may provide additional cardiovascular benefit. 2

Why This Conversion May Not Be Ideal

  • Current hypertension guidelines do not recommend alpha-blockers like doxazosin as preferred antihypertensive agents unless there are compelling indications such as benign prostatic hyperplasia. 6

  • If blood pressure remains uncontrolled on amlodipine 5mg alone, guideline-recommended approaches include adding an ACE inhibitor/ARB or thiazide diuretic rather than switching to doxazosin. 6

  • Combination therapy with amlodipine plus an ACE inhibitor/ARB or thiazide provides superior cardiovascular outcomes compared to monotherapy with alternative agents. 6

  • If switching is necessary due to amlodipine intolerance, consider alternative first-line agents (ACE inhibitors, ARBs, or thiazide diuretics) before doxazosin unless the patient has BPH requiring treatment. 6, 1

References

Research

The antihypertensive effects of doxazosin: a clinical overview.

British journal of clinical pharmacology, 1986

Research

Amlodipine in hypertension: an overview of the clinical dossier.

Journal of cardiovascular pharmacology, 1988

Guideline

Adding Antihypertensive Medication to Amlodipine Twice Daily

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.